What percentage of patients experience diarrhea after taking Nitrofurantoin (antibiotic)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diarrhea Incidence with Nitrofurantoin

Approximately 5-6% of patients experience diarrhea as a side effect when taking nitrofurantoin. 1, 2

Gastrointestinal Side Effects of Nitrofurantoin

Nitrofurantoin is commonly used for treating and preventing urinary tract infections, but like many antibiotics, it can cause gastrointestinal side effects:

  • Diarrhea is reported in approximately 1-3% of patients in clinical trials, though some studies report rates up to 5-6% 1, 2
  • Nausea is more common than diarrhea, occurring in 2-3% of patients taking nitrofurantoin 1
  • Gastrointestinal symptoms typically occur early in the treatment course and are usually mild to moderate in severity 3

Comparison with Other Antibiotics

  • Nitrofurantoin has a lower incidence of diarrhea compared to many other antibiotics used for UTIs 3
  • In comparative studies, nitrofurantoin showed fewer gastrointestinal side effects overall compared to other antibiotics, with diarrhea specifically occurring in about 1% of patients (compared to similar rates with fosfomycin) 1, 2
  • The most common adverse effects with nitrofurantoin are nausea and headache rather than diarrhea 4

Factors Affecting Diarrhea Risk

  • Higher doses of nitrofurantoin (100 mg) are associated with increased risk of gastrointestinal side effects compared to lower doses (50 mg) 5
  • Extended treatment courses may increase the risk of adverse effects, including diarrhea 6
  • Taking nitrofurantoin with food can help reduce the incidence of gastrointestinal side effects, including diarrhea 3

Clinical Management Considerations

  • Most cases of nitrofurantoin-associated diarrhea are mild and self-limiting, rarely requiring discontinuation of therapy 2, 3
  • Severe or persistent diarrhea occurs in <1% of patients taking nitrofurantoin 1, 2
  • If diarrhea develops, patients should be monitored for signs of dehydration, especially in elderly patients or those with comorbidities 3

Comparative Incidence

  • Diarrhea incidence with nitrofurantoin (1-6%) is significantly lower than with many chemotherapeutic agents, which can cause diarrhea in 30-50% of patients 7
  • The risk of diarrhea with nitrofurantoin is lower than with fluoroquinolones and comparable to fosfomycin 1, 2

When prescribing nitrofurantoin, patients should be informed about the possibility of diarrhea as a side effect, but reassured that it is relatively uncommon compared to other antibiotics and typically mild when it does occur.

References

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022

Research

Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.